These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1339432)

  • 21. A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway.
    Spies T; Bresnahan M; Bahram S; Arnold D; Blanck G; Mellins E; Pious D; DeMars R
    Nature; 1990 Dec 20-27; 348(6303):744-7. PubMed ID: 2259384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of H-2Kb-specific peptides to TAP and major histocompatibility complex class I in microsomes from wild-type, TAP1, and beta2-microglobulin mutant mice.
    Wang P; Raynoschek C; Svensson K; Ljunggren HG
    J Biol Chem; 1996 Oct; 271(40):24830-5. PubMed ID: 8798757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells.
    Bellone M; Iezzi G; Manfredi AA; Protti MP; Dellabona P; Casorati G; Rugarli C
    Eur J Immunol; 1994 Nov; 24(11):2691-8. PubMed ID: 7525300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low temperature and peptides favor the formation of class I heterodimers on RMA-S cells at the cell surface.
    Rock KL; Gramm C; Benacerraf B
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4200-4. PubMed ID: 1709736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell recognition of QA-1b antigens on cells lacking a functional Tap-2 transporter.
    Aldrich CJ; Waltrip R; Hermel E; Attaya M; Lindahl KF; Monaco JJ; Forman J
    J Immunol; 1992 Dec; 149(12):3773-7. PubMed ID: 1460275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation.
    Chevalier MS; Daniels GM; Johnson DC
    J Virol; 2002 Aug; 76(16):8265-75. PubMed ID: 12134032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters.
    Deverson EV; Gow IR; Coadwell WJ; Monaco JJ; Butcher GW; Howard JC
    Nature; 1990 Dec 20-27; 348(6303):738-41. PubMed ID: 1979660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonclassical behavior of the thymus leukemia antigen: peptide transporter-independent expression of a nonclassical class I molecule.
    Holcombe HR; Castaño AR; Cheroutre H; Teitell M; Maher JK; Peterson PA; Kronenberg M
    J Exp Med; 1995 Apr; 181(4):1433-43. PubMed ID: 7699328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region.
    Bahram S; Arnold D; Bresnahan M; Strominger JL; Spies T
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10094-8. PubMed ID: 1946428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presentation of viral antigen controlled by a gene in the major histocompatibility complex.
    Cerundolo V; Alexander J; Anderson K; Lamb C; Cresswell P; McMichael A; Gotch F; Townsend A
    Nature; 1990 May; 345(6274):449-52. PubMed ID: 2342577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzyme immunoassay detection of induction of MHC class I expression by synthetic peptides from the E6 and E7 regions of human papillomavirus type 16.
    Dillner J
    J Immunol Methods; 1994 Jan; 167(1-2):195-205. PubMed ID: 8308275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophages present exogenous antigens by class I major histocompatibility complex molecules via a secretory pathway as a consequence of interferon-gamma activation.
    Martín-Orozco N; Isibasi A; Ortiz-Navarrete V
    Immunology; 2001 May; 103(1):41-8. PubMed ID: 11380691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally relevant interaction with TAP.
    Lewis JW; Neisig A; Neefjes J; Elliott T
    Curr Biol; 1996 Jul; 6(7):873-83. PubMed ID: 8805302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A molecular model of MHC class-I-restricted antigen processing.
    Monaco JJ
    Immunol Today; 1992 May; 13(5):173-9. PubMed ID: 1386516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes.
    Brown MG; Driscoll J; Monaco JJ
    Nature; 1991 Sep; 353(6342):355-7. PubMed ID: 1922341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recruitment of MHC class I molecules by tapasin into the transporter associated with antigen processing-associated complex is essential for optimal peptide loading.
    Tan P; Kropshofer H; Mandelboim O; Bulbuc N; Hämmerling GJ; Momburg F
    J Immunol; 2002 Feb; 168(4):1950-60. PubMed ID: 11823531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation.
    Momburg F; Ortiz-Navarrete V; Neefjes J; Goulmy E; van de Wal Y; Spits H; Powis SJ; Butcher GW; Howard JC; Walden P
    Nature; 1992 Nov; 360(6400):174-7. PubMed ID: 1299222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of induction of primary virus-specific cytotoxic T lymphocyte responses.
    De Bruijn ML; Nieland JD; Schumacher TN; Ploegh HL; Kast WM; Melief CJ
    Eur J Immunol; 1992 Nov; 22(11):3013-20. PubMed ID: 1425925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of medial class I histocompatibility antigens on RMA-S mutant cells.
    Hermel E; Grigorenko E; Lindahl KF
    Int Immunol; 1991 Apr; 3(4):407-12. PubMed ID: 1878342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration of H-2b expression and processing of endogenous antigens in the MHC class I pathway by fusion of a lymphoma mutant to L cells of the H-2k haplotype.
    Ohlén C; Bastin J; Ljunggren HG; Imreh S; Klein G; Townsend AR; Kärre K
    Eur J Immunol; 1990 Aug; 20(8):1873-6. PubMed ID: 2120065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.